Wells Fargo & Company »

Aerovate Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $66k 2.9k 22.63
2023-09-30 $31k 2.3k 13.57
2023-06-30 $72k 4.2k 17.15
2022-09-30 $0 28 0.00
2022-06-30 $2.0k 118 16.95
2022-03-31 $27k 1.5k 18.04
2021-12-31 $52k 4.5k 11.69
2021-09-30 $999 55 18.18